FDA Grants Regenerative Medication Superior Remedy (RMAT) designation to Autolus’ CAR T cell remedy, obe-cel, for the remedy of grownup B-ALL

Autolus Restricted LONDON, April 25, 2022 (GLOBE NEWSWIRE) — Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharmaceutical firm creating next-generation programmed T cell therapies, right this moment introduced that the U.S. Meals and Drug Administration (FDA) has granted Regenerative Medication Superior Remedy (RMAT) designation to its lead gene remedy obecabatagene autoleucel (obe-cel), a CD19-directed autologous…

Read More

European Medicines Company Commences Evaluation of Novel Gene Remedy Candidate Etranacogene Dezaparvovec for Individuals with Hemophilia B

Advertising and marketing Authorization Software (MAA) for etranacogene dezaparvovec might be reviewed beneath accelerated evaluation and has the potential to be the primary gene remedy for sufferers dwelling with hemophilia B MAA submitting is supported by the section 3 HOPE-B examine which demonstrated sturdy and sustained therapeutic impact after a single infusion Milestone underscores CSL…

Read More

May New Remedy for Meals ‘Cues’ Enhance Weight Loss?

An intensive 1-year habits remedy program aimed toward altering an individual’s response to meals “cues” would possibly assist folks with obesity lose a modest quantity of weight, a randomized scientific trial suggests. “Sufferers who’re food-cue delicate typically really feel uncontrolled with their consuming; they can’t resist meals and/or can’t cease interested by meals,” stated lead creator…

Read More